DMC Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-735
Closed -$382K 137
2024
Q4
$382K Sell
735
-142
-16% -$78.1K 0.31% 97
2024
Q3
$542K Buy
877
+138
+19% +$81.7K 0.44% 79
2024
Q2
$409K Buy
739
+51
+7% +$29.2K 0.35% 83
2024
Q1
$400K Buy
688
+12
+2% +$6.73K 0.35% 88
2023
Q4
$359K Buy
676
+84
+14% +$40.7K 0.34% 91
2023
Q3
$300K Buy
592
+84
+17% +$44.8K 0.28% 91
2023
Q2
$265K Buy
508
+8
+2% +$4.32K 0.27% 104
2023
Q1
$285K Buy
500
+118
+31% +$66.5K 0.29% 101
2022
Q4
$211K Buy
+382
New +$202K 0.24% 106
2022
Q1
Sell
-421
Closed -$233K 130
2021
Q4
$233K Buy
+421
New +$263K 0.2% 118

Other funds holding TMO

DMC Group's TMO Position: Q1 2025 in Review

DMC Group sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 735 shares — an estimated $382K sold.

DMC Group first reported a position in TMO in Q4 2021 and held it in 10 quarters. The position peaked at $542K in Q3 2024. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • DMC Group reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • DMC Group sold 735 Thermo Fisher Scientific shares in Q1 2025, an estimated $382K.
  • DMC Group first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 10 quarters.
  • DMC Group's Thermo Fisher Scientific position peaked at $542K in Q3 2024.
  • 2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on DMC Group's 13F filing for Q1 2025, filed 30 Apr 2025.